Advancements in skin cancer research have given way to nonsurgical treatment methods. Anthony Rossi, MD, shares the latest information in the session, “What’s Next: Nonsurgical and Adjuvant Treatments for Skin Cancers” (FOC U005) from 7:30 to 8:30 a.m. Friday, in Room 103A.
While surgery is the standard of care for most skin cancers, certain cases will allow for nonsurgical therapy, especially when it is not curative or feasible. The session, which is designed for dermatologists, Mohs surgeons, and dermatologic surgeons who treat skin malignancies, will detail specific treatments, including adjuvant radiation for high-risk cancers, imiquimod for lentigo maligna, and intralesional chemotherapy for squamous cell carcinomas.
Following the session, attendees will have a better understanding of the efficacy and limitations of such therapies, including a look at supporting data. Additionally, attendees are expected to become more skilled at evaluating the role of adjuvant and nonsurgical treatments in the management of skin cancers and utilizing nonsurgical treatment options in select patient populations.
Attendees can earn 1 CME credit for the course; no tuition or ticket is required for the session.